US Inhaled Insulin Dose Titration Study
Public ClinicalTrials.gov record NCT00246623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multicenter Study Assessing the Effects of Forced Exubera Dose Titration on Glycemic Control in Patients With Suboptimally Controlled Type 2 Diabetes on Two or More Oral Antidiabetic Agents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will examine how to dose Exubera (inhaled insulin) in patients who are not well controlled on two or more diabetes pills. This study should show that a large number of patients enrolled in the study can reach the target Hemoglobin A1C levels (7% or less) that have been set by the American Diabetes Association (ADA). Target goals should be achieved by adjusting the Exubera dose either weekly or twice weekly. Patients will also receive nutritional counseling and diabetes education as part of the study.
Study identification
- NCT ID
- NCT00246623
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Exubera (inhaled insulin) Drug
- 8-point glucose diary (to assess pre- and post prandial glucoses) Procedure
- Meal Tolerance Test Procedure
- 24-hour continuous glucose monitoring (at select sites) Procedure
- Pulmonary Function Testing Procedure
- Hypoglycemic Event Monitoring Procedure
- Laboratory Assessments Procedure
- Nutritional Counseling and Diabetes Education Behavioral
Drug · Procedure · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Mar 2007 (Actual)
- Last update posted
- Feb 8, 2008
2005 – 2007
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | New Britain | Connecticut | — | — |
| Pfizer Investigational Site | Norwalk | Connecticut | — | — |
| Pfizer Investigational Site | Hollywood | Florida | — | — |
| Pfizer Investigational Site | Atlanta | Georgia | — | — |
| Pfizer Investigational Site | Boise | Idaho | — | — |
| Pfizer Investigational Site | Hayden | Idaho | — | — |
| Pfizer Investigational Site | Baton Rouge | Louisiana | — | — |
| Pfizer Investigational Site | Boston | Massachusetts | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Syracuse | New York | — | — |
| Pfizer Investigational Site | Dallas | Texas | — | — |
| Pfizer Investigational Site | El Paso | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Bennington | Vermont | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00246623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2008 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00246623 live on ClinicalTrials.gov.